Drug intelligence / Profile preview

Visiodoron Euphrasia comp.

Development stage
Unknown
Lead developer
Weleda
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Ophthalmic
01

Overview

Visiodoron Euphrasia comp. eye ointment is an anthroposophic and homeopathic medicinal product developed by Weleda AG. It is a botanical combination therapy containing three primary active herbal ingredients: *Echinacea angustifolia* (coneflower), *Euphrasia* (eyebright), and *Calendula officinalis* (marigold). The product is specifically indicated for the treatment of non-severe eye inflammations, including conjunctivitis, blepharitis (eyelid margin inflammation), hordeolum (stye), and chalazion. Formulated as a preservative-free ointment, it is designed for topical ophthalmic application, particularly for nighttime use to provide prolonged contact with the ocular surface. As an anthroposophic preparation, it aims to stimulate the body's inherent self-healing processes to resolve inflammation and soothe irritation without targeting a single specific molecular pathway.

Brand names
Visiodoron Euphrasia comp.Visiodoron Euphrasia comp. eye ointment
Other names
Visiodoron Euphrasia comp. Augensalbe
02

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)MMP12 (Macrophage Metalloelastase)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Visiodoron Euphrasia comp..

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Visiodoron Euphrasia comp..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call